Clinical Trial Update: A Study of Safety and Efficacy of Sirolimus for Injection (Albumin-bound) in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumor (PEComa) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for sirolimus (albumin-bound) in advanced malignant PEComa across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Perivascular Epithelioid Cell Tumor

Drugs mentioned

• Sirolimus (Albumin-Bound) (sirolimus)

Snippet

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Conditions: Advanced Malignant Perivascular Epithelioid Cell Tumor (PEComa) | Phase 1, Phase 2 | Status: UNKNOWN